BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30195733)

  • 1. Glucagon-like peptide-1 receptor internalisation controls spatiotemporal signalling mediated by biased agonists.
    Fletcher MM; Halls ML; Zhao P; Clydesdale L; Christopoulos A; Sexton PM; Wootten D
    Biochem Pharmacol; 2018 Oct; 156():406-419. PubMed ID: 30195733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonist.
    Pickford P; Lucey M; Rujan RM; McGlone ER; Bitsi S; Ashford FB; Corrêa IR; Hodson DJ; Tomas A; Deganutti G; Reynolds CA; Owen BM; Tan TM; Minnion J; Jones B; Bloom SR
    Mol Metab; 2021 Sep; 51():101242. PubMed ID: 33933675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct roles of the extracellular surface residues of glucagon-like peptide-1 receptor in β-arrestin 1/2 signaling.
    Lei S; Meng Q; Liu Y; Liu Q; Dai A; Cai X; Wang MW; Zhou Q; Zhou H; Yang D
    Eur J Pharmacol; 2024 Apr; 968():176419. PubMed ID: 38360293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors.
    Yuliantie E; Darbalaei S; Dai A; Zhao P; Yang D; Sexton PM; Wang MW; Wootten D
    Biochem Pharmacol; 2020 Jul; 177():114001. PubMed ID: 32360365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of efficacy- versus affinity-driven agonism with biased GLP-1R ligands P5 and exendin-F1.
    Marzook A; Chen S; Pickford P; Lucey M; Wang Y; Corrêa IR; Broichhagen J; Hodson DJ; Salem V; Rutter GA; Tan TM; Bloom SR; Tomas A; Jones B
    Biochem Pharmacol; 2021 Aug; 190():114656. PubMed ID: 34129856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of G protein-coupled receptor kinases in GLP-1R β-arrestin recruitment and internalisation.
    McNeill SM; Lu J; Marion C Carino C; Inoue A; Zhao P; Sexton PM; Wootten D
    Biochem Pharmacol; 2024 Apr; 222():116119. PubMed ID: 38461904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disconnect between signalling potency and in vivo efficacy of pharmacokinetically optimised biased glucagon-like peptide-1 receptor agonists.
    Lucey M; Pickford P; Bitsi S; Minnion J; Ungewiss J; Schoeneberg K; Rutter GA; Bloom SR; Tomas A; Jones B
    Mol Metab; 2020 Jul; 37():100991. PubMed ID: 32278079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptors.
    Darbalaei S; Yuliantie E; Dai A; Chang R; Zhao P; Yang D; Wang MW; Sexton PM; Wootten D
    Biochem Pharmacol; 2020 Oct; 180():114150. PubMed ID: 32682761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking.
    Lucey M; Ashik T; Marzook A; Wang Y; Goulding J; Oishi A; Broichhagen J; Hodson DJ; Minnion J; Elani Y; Jockers R; Briddon SJ; Bloom SR; Tomas A; Jones B
    Mol Pharmacol; 2021 Oct; 100(4):319-334. PubMed ID: 34315812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the Gαq pathway.
    Thompson A; Kanamarlapudi V
    Biochem Pharmacol; 2015 Jan; 93(1):72-84. PubMed ID: 25449603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GLP-1R as a model for understanding and exploiting biased agonism in next-generation medicines.
    Douros JD; Mokrosinski J; Finan B
    J Endocrinol; 2024 May; 261(2):. PubMed ID: 38451873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism.
    Lei S; Clydesdale L; Dai A; Cai X; Feng Y; Yang D; Liang YL; Koole C; Zhao P; Coudrat T; Christopoulos A; Wang MW; Wootten D; Sexton PM
    J Biol Chem; 2018 Jun; 293(24):9370-9387. PubMed ID: 29717000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1.
    Hager MV; Clydesdale L; Gellman SH; Sexton PM; Wootten D
    Biochem Pharmacol; 2017 Jul; 136():99-108. PubMed ID: 28363772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxyntomodulin differentially affects glucagon-like peptide-1 receptor beta-arrestin recruitment and signaling through Galpha(s).
    Jorgensen R; Kubale V; Vrecl M; Schwartz TW; Elling CE
    J Pharmacol Exp Ther; 2007 Jul; 322(1):148-54. PubMed ID: 17395766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin-converting enzyme-1 regulates glucagon-like peptide-1 receptor signalling and resensitisation.
    Lu J; Willars GB
    Biochem J; 2019 Feb; 476(3):513-533. PubMed ID: 30626614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor Internalisation.
    Thompson A; Stephens JW; Bain SC; Kanamarlapudi V
    PLoS One; 2016; 11(4):e0154229. PubMed ID: 27100083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors.
    Jones B; McGlone ER; Fang Z; Pickford P; Corrêa IR; Oishi A; Jockers R; Inoue A; Kumar S; Görlitz F; Dunsby C; French PMW; Rutter GA; Tan T; Tomas A; Bloom SR
    J Biol Chem; 2021; 296():100133. PubMed ID: 33268378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand-Specific Factors Influencing GLP-1 Receptor Post-Endocytic Trafficking and Degradation in Pancreatic Beta Cells.
    Fang Z; Chen S; Manchanda Y; Bitsi S; Pickford P; David A; Shchepinova MM; Corrêa IR; Hodson DJ; Broichhagen J; Tate EW; Reimann F; Salem V; Rutter GA; Tan T; Bloom SR; Tomas A; Jones B
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The complexity of signalling mediated by the glucagon-like peptide-1 receptor.
    Fletcher MM; Halls ML; Christopoulos A; Sexton PM; Wootten D
    Biochem Soc Trans; 2016 Apr; 44(2):582-8. PubMed ID: 27068973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances exendin-4-mediated weight loss in obese mice.
    Brown JD; McAnally D; Ayala JE; Burmeister MA; Morfa C; Smith L; Ayala JE
    Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R595-R608. PubMed ID: 29949410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.